Chitosan: A propitious biopolymer for Drug Delivery

Current Drug Delivery

Volumn 12, Issue 4, 2015, Pages 369-381

  Duttagupta, Dibyangana S ^a   Jadhav, Varsha M ^a   Kadam, Vilasrao J ^a  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

Biocompatible; Biodegradable; Chitosan; Controlled release; Drug delivery; Mucoadhesive character

Indexed keywords

BIOPOLYMER; CELLULOSE; CHITIN; CHITOSAN; POLYSACCHARIDE; DRUG CARRIER; DRUG DOSAGE FORM;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL STRUCTURE; COLON; CONTROLLED DRUG RELEASE; DEACETYLATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TARGETING; HUMAN; HYDROGEL; INTRAPULMONARY DRUG ADMINISTRATION; MUCOADHESION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; CHEMISTRY; DRUG ADMINISTRATION ROUTE; DRUG DOSAGE FORM; MEDICINAL CHEMISTRY; PATIENT SAFETY; PHARMACEUTICS; PROCEDURES; RISK ASSESSMENT;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DOSAGE FORMS; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; PATIENT SAFETY; RISK ASSESSMENT; TECHNOLOGY, PHARMACEUTICAL;

EID: 84930949438     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201812666150310151657     Document Type: Article

References (123)

1. Kumar, M.N.; Muzzarelli, R.A.; Muzzarelli, C.; Sashiwa, H.; Domb, A.J. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev., 2004, 104, 6017-6084.
2. Shepherd, R.; Reader, S.; Falshaw, A. Chitosan functional properties. Glycoconj. J., 1997, 14, 535-542.
3. Rhazi, M.; Desbrieres, J.; Tolaimate, A.; Alagui, A.; Vottero, P. Investigation of different natural sources of chitin: influence of the source and deacetylation process on the physicochemical characteristics of chitosan. Polym. Int., 2000, 49, 337-344.
4. Sonia, T.A.; Sharma, C.P. Chitosan and its derivatives for drug delivery perspective. Adv. Polym. Sci., 2011, 243, 23-54.
5. Nwe, N.; Chandrkrachang, S.; Stevens, W.F.; Maw, T.; Tan, T.K.; Khor, E.; Wong, S.M. Production of fungal chitosan by solid state and submerged fermentation, Carbohydr. Polym., 2002, 49, 235-237.
6. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res., 1998, 15, 1142-1144.
7. Kasaai, M.R. Various methods for determination of the degree of N-acetylation of chitin and chitosan: A review. J. Agric. Food Chem., 2009, 57, 1667-1676.
8. Franca, E.F.; Freitas, L.C.; Lins, R.D. Chitosan molecular structure as a function of N-acetylation. Biopolymers, 2011, 95, 448-460.
9. Tiyaboonchai, W. Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ. J., 2003, 11, 51-66.
10. Chung, Y.C.; Fang, C.; Fung, C. Preparation and characterization of water-soluble chitosan produced by Maillard reaction. Fisheries Sci., 2006, 72, 1096-1103.
11. Errington, N.; Harding, S.E.; Varum, K.M.; Illum, L. Hydrodynamic characterisation of chitosan varying in molecular weight and degree of acetylation. Int. J. Biol. Macromol., 1993, 15, 113-117.
12. Dutta, P.K.; Ravikumar, M.N.V.; Dutta, J. Chitin and chitosan for versatile applications. JMS Polymer Rev., 2002, 42, 307-354.
13. Hassan, E.E.; Gallo, J.M. A simple rheological method for the in vitro assessment of mucin polymer bioadhesive bond strength. Pharm. Res., 1990, 7, 491-495.
14. Gaserod, O.; Jolliffe, A.G.; Hampson, F.C.; Dettmar, P.W.; Skjak-Braek, G. The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan, Int. J. Pharm., 1998, 175, 237-246.
15. Lehr, C.M.; Bouwstra, J.A.; Schacht, E.H.; Junginger, H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm., 1992, 78, 43-48.
16. He, P.; Davis, S.S.; Illum, L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm., 1998, 166, 75-88.
17. Luessen, H.L.; de Leeuw, B.J.; Langemeyer, M.W.; de Boer, A.B.; Verhoef, J.C.; Junginger, H.E. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res., 1996, 13, 1668-1672.
18. Jintapattanakit, A.; Junyaprasert, V.B.; Kissel, T. The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake. J. Pharm. Sci., 2009, 98, 4818-4830.
19. Werle, M.; Bernkop-Schnurch, A. Thiolated chitosans: useful excipients for oral drug delivery. J. Pharm. Pharmacol., 2008, 60, 273-281.
20. Schipper, N.G.; Olsson, S.; Hoogstraate, J.A.; deBoer, A.G.; Varum, K.M.; Artursson, P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res., 1997, 14, 923-929.
21. Dodane, V.; Khan, M.A.; Merwin, J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm., 1999, 182, 21-32.
22. Illum, L.; Farraj, N.F.; Davis, S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res., 1994, 11, 1186-1189.
23. Schipper, N.G.M.; Varum, K.M.; Artursson, P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (caco-2) cells. Pharm. Res., 1996, 13, 1686-1692.
24. Shah, P.; Jogani, V.; Mishra, P.; Mishra, A.K.; Bagchi, T.; Misra, A. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers. J. Pharm. Sci., 2007, 96, 2710-2722.
25. Trapani, A.; Lopedota, A.; Franco, M.; Cioffi, N.; Ieva, E.; Garcia-Fuentes, M.; Alonso, M.J. A comparative study of chitosan and chitosan /cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Eur. J. Pharm. Biopharm., 2010, 75, 26-32.
26. Langoth, N.; Kahlbacher, H.; Schoffmann, G.; Schmerold, I.; Schuh, M.; Franz, S.; Kurka, P.; Bernkop-Schnurch, A. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm. Res., 2006, 23, 573-579.
27. Bhattarai, N.; Gunn, J.; Zhang, M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev., 2010, 62, 83-99.
28. Luppi, B.; Bigucci, F.; Cerchiara, T.; Zecchi, V. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin. Drug Deliv., 2010, 7, 811-828.
29. Gupta, S.; Vyas, S.P. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci. Pharm., 2010, 78, 959-976.
30. Sakloetsakun, D.; Hombach, J.M.; Bernkop-Schnurch, A. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials., 2009, 30, 6151-6157.
31. Nigalaye, A.G.; Adusumili, P.; Bolton, S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev. Ind. Pharm., 1990, 16, 449-467.
32. Mi, F.L.; Her, N.L.; Kaun, C.Y.; Wong, T.B.; Shyu, S.S. Chitosan tablets for controlled drug release of theophylline: effect of polymer drug wet or dry blending and anionic-cationic interpolymer. J. Appl. Polym. Sci., 1997, 66, 2495-2499.
33. Sawayanagi, Y.; Nambu, N.; Nagai, T. Enhancement of dissolution properties of griseofulvin from ground mixture with chitin and chitosan. Chem. Pharm. Bull., 1982, 30, 4464-4467.
34. Sandford, P.A. Chitosan and alginate: new forms of commercial interest. Am. Chem. Soc. Div. Polym. Chem., 1990, 31, 628-629.
35. Alonso, M.J.; Sanchez, A. The potential of chitosan in ocular drug delivery. J. Pharm. Pharmacol., 2003, 55, 1451-1463.
36. Felt, O.; Furrer, P.; Mayer, J.M.; Plazonnet, B.; Buri, P.; Gurny, R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm., 1999, 180, 185-193.
37. Felt, O.; Carrel, A.; Baehni, P.; Buri, P.; Gurny, R. Chitosan as tearsubstitute: a wetting agent endowed with antimicrobial efficacy. J. Ocular Pharmacol., 2000, 16, 261-270.
38. Genta, I.; Conti, B.; Perugini, P.; Pavaneto, F.; Spadaro, A.; Puglisi, G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharm. Pharmacol., 1997, 49, 737-742.
39. Calvo, P.; Vila-Jato, J. L.; Alonso, M. J. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm., 1997, 153, 41-50.
40. De Campos, A.; Sanchez, A.; Alonso, M. J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm., 2001, 224, 159-168.
41. Motwani, S.K.; Chopra, S.; Talegaonkar, S.; Kohli, K.; Ahmad, F.J.; Khar, R.K.; Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimization and in vitro characterization. Eur. J. Pharm. Biopharm., 2008, 68, 513-525.
42. Illum, L. Nasal drug delivery - possibilities, problems and solutions. J. Control. Release, 2003, 87, 187-198.
43. Charlton, S.; Jones, N.S.; Davis, S.S.; Illum, L. Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device. Eur. J. Pharm. Sci., 2007, 30, 295-302.
44. Illum, L.; Watts, P.; Fisher, A.N.; Hinchcliffe, M.; Norbury, H.; Jabbal-Gill, I.; Nankervis, R.; Davis, S.S. Intranasal delivery of morphine. J. Pharmacol. Exp. Ther., 2002, 301, 391-400.
45. Nokhodchi, A.; Tailor, A. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophilline from polymeric matrices. FARMACO., 2004, 59, 999-1004.
46. Ruel-Gariepy, E.; Leroux, J.C. In situ-forming hydrogels- review of temperature-sensitive systems. Eur. J. Pharm. Biopharm., 2004, 58, 409-426.
47. Varshosaz, J.; Sadrai, H.; Heidari, A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv., 2006, 13, 31-38.
48. Ishikawa, F.; Murano, M.; Hiraishi, M.; Yamaguchi, T.; Tamai, I.; Tsuji, A. Insoluble powder formulation as an effective nasal drug delivery system. Pharm. Res., 2002, 19, 1097-1104.
49. Dyer, A.M.; Hinchcliffe, M.; Watts, P.; Castile, J.; Jabbal-Gill, I.; Nankervis, R.; Smith, A.; Illum, L. Nasal delivery of Insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm. Res., 2002, 19, 998-1008.
50. Gavini, E.; Hegge, A.B.; Rassu, G. Sanna, V.; Testa, C.; Pirisino, G.; Karlsen, J.; Giunchedi, P. Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int. J. Pharm., 2006, 307, 9-15.
51. Sinha, V.R.; Singla, A.K.; Wadhawan, S.; Kaushik, R.; Kumria, R.; Bansal, K.; Dhawan, S. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm., 2004, 274, 1-33.
52. Abdel Mouez, M.; Zaki, N.M.; Mansour, S.; Geneidi, A.S. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres. Eur. J. Pharm. Sci., 2014, 51, 59-66.
53. Brooking, J.; Davis, S.S.; Illum, L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target, 2001, 9, 267-279.
54. Amidi, M.; Romeijn, S.G.; Borchard, G.; Junginger, H.E.; Hennink, W.E.; Jiskoot, W. Preparation and characterization of protein loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release., 2006, 111, 107-116.
55. Wang, X.; Zheng, C.; Wu, Z.; Teng, D.; Zhang, X.; Wang, Z.; Li, C. Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J. Biomed. Mater. Res. B. Appl. Biomater., 2009, 88, 150-161.
56. Mistry, A.; Stolnik, S.; Illum, L. Nanoparticles for direct nose-tobrain delivery of drugs. Int. J. Pharm., 2009, 379, 146-157.
57. Wang, X.; Chi, N.; Tang, X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur. J. Pharm. Biopharm., 2008, 70, 735-740.
58. Al-Ghananeem, A.M.; Saeed, H.; Florence, R.; Yokel, R.A.; Malkawi, A.H. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses. J. Drug Target., 2010, 18, 381-388.
59. Haque, S.; Shadab, M.; Fazil, M.; Kumar, M.; Sahni, J.K.; Ali, J.; Baboota, S. Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation. Carbohyd. Polym., 2012, 89, 72-79.
60. Hejazi, R.; Amiji, M.Chitosan-based gastrointestinal delivery systems. J. Control. Release., 2003, 89, 151-165.
61. Senel, S.; Hincal, A.A. Drug penetration enhancement via buccal route: possibilities and limitations. J. Control. Release, 2001, 72, 133-144.
62. Senel, S.; Ikinci, G.; Kas, S.; Yousefi-Rad, A.; Sargon, M.F.; Hincal, A.A. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int. J. Pharm., 2000, 193, 197-203.
63. Senel, S.; Kremer, M.J.; Kas, S.; Wertz, P.W.; Hincal, A.A.; Squier, C.A. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials, 2000, 21, 2067-2071.
64. Remunan-Lopez, C.; Portero, A.; Vila-Jato, J.L.; Alonso, M.J. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Release, 1998, 55, 143-152.
65. Sandri, G.; Rossi, S.; Bonferoni, M. C.; Ferrari, F.; Zambito, Y.; Di Colo, G.; Caramella, C. Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int. J. Pharm., 2005, 297, 146-155.
66. Langoth, N.; Kahlbacher, H.; Schoffmann, G.; Schmerold, I.; Schuh, M.; Franz, S.; Kurka, P.; Bernkop-Schnurch, A. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm. Res., 2006, 23, 573-579.
67. Goswami, T.; Jasti, B.; Li, X. Sublingual drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 2008, 25, 449-484.
68. Miyazaki, S.; Nakayama, A.; Oda, M.; Takada, M.; Attwood, D. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol. Pharm. Bull., 1994, 17, 745-747.
69. Miyazaki, S.; Nakayama, A.; Oda, M.; Takada, M.; Attwood, D. Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate. Int. J. Pharm., 1995, 118, 257-263.
70. Pahwa, R.; Saini, N.; Kumar, V.; Kohli, K. Chitosan-based gastroretentive floating drug delivery technology: an updated review. Expert Opin. Drug Deliv., 2012, 9, 525-539.
71. Inouye, K.; Machida, Y.; Sannan, T.; Nagai, T. Buoyant sustained release granules based on chitosan. Drug Des. Deliv., 1989, 4, 55-67.
72. Miyazaki, S.; Yamaguchi, H.; Yokouchi, C.; Takada, M.; Hou, W.M. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chem. Pharm. Bull., 1988, 36, 4033-4038.
73. Eldeen, A.B.; Alsarra, I.A.; Al-Mohizea, A.M. Chitosan beads as a new gastroretentive system of verapamil. Sci. Pharm., 2006, 74, 175-188.
74. Rajnikanth, P.S.; Mishra, B. Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. Pylori. Acta Pharm., 2007, 57, 413-427.
75. Sahasathian, T.; Praphairaksit, N.; Muangsin, N. Mucoadhesive and floating chitosan coated alginate beads for controlled gastric release of amoxicillin. Arch. Pharm. Res., 2010, 33, 889-899.
76. Pison, U.; Welte, T.; Giersig, M.; Groneberg, D.A. Nanomedicine for respiratory diseases. Eur. J. Pharmacol., 2006, 533, 341-350.
77. Sung, J.C.; Pulliam, B.L.; Edwards, D.A. Nanoparticles for drug delivery to the lungs. Trends Biotechnol., 2007, 25, 563-570.
78. Scheuch, G.; Kohlhaeufl, M.J.; Brand, P.; Siekmeier, R. Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv. Drug Deliv. Rev., 2006, 58, 996-1008.
79. Grenha, A.; Seijo, B.; Remunan-Lopez, C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur. J. Pharm. Sci., 2005, 25, 427-37.
80. Learoyd, T.P.; Burrows, J.L.; French, E.; Seville, P.C. Chitosanbased spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur. J. Pharm. Biopharm., 2008, 68, 224-234.
81. Yamamoto, H.; Kuno, Y.; Sugimoto, S.; Takeuchi, H.; Kawashima, Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J. Control. Release, 2005, 102, 373-381.
82. Amidi, M.; Pellikaan, H.C.; de Boer, A. H.; Crommelin, D. J.; Hennink, W. E.; Jiskoot, W. Preparation and physicochemical characterization of supercritically dried insulin- loaded microparticles for pulmonary delivery. Eur. J. Pharm. Biopharm., 2008, 68, 191-200.
83. Prausnitz, M.R.; Langer, R. Transdermal drug delivery. Nat. Biotechnol., 2008, 26, 1261-1268.
84. Prausnitz, M.R.; Mitragotri, S.; Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov., 2004, 3, 115-124.
85. Thacharodi, D.; Rao, K.P. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride. Biomaterials, 1995, 16, 145-148.
86. Thacharodi, D.; Rao, K.P. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations. Biomaterials, 1996, 17, 1307-1311.
87. Elmotasem, H. Chitosan-alginate blend films for the transdermal delivery of meloxicam. Asian J. Pharm. Sci., 2008, 3, 12-29.
88. Hafner, A.; Lovric, J.; Pepic, I.; Filipovic-Grcic, J. Lecithin/ chitosan nanoparticles for transdermal delivery of melatonin. J. Microencapsul., 2011, 28, 807-815.
89. Khalil, S.K.; El-Feky, G.S.; El-Banna, S.T.; Khalil, W.A. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydr. Polym., 2012, 90, 1244-1253.
90. Hemant, K.S.Y.; Shivakumar, H.G. Development of chitosan acetate films for transdermal delivery of propranolol hydrochloride. Tropical J. Pharm. Res., 2010, 9, 197-203.
91. Chourasia, M.K.; Jain, S.K. Polysaccharides for colon targeted drug delivery. Drug Deliv., 2004, 11, 129-148.
92. Walker, W.A.; lsselbacher, K.J. Uptake and transport of macromolecules by the intestine. Gastroenterology, 1974, 67, 531-550.
93. Tozaki, H.; Komoike, J.; Tada, C.; Maruyama, T.; Terabe, A.; Suzuki, T.; Yamamoto, A.; Muranishi, S. Chitosan capsules for colon- specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci., 1997, 86, 1016-1021.
94. Tozaki, H.; Odoriba, T.; Okada, N.; Fujita, T.; Terabe, A.; Suzuki, T.; Okabe, S.; Muranishi, S.; Yamamoto, A. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5- aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J. Control. Release, 2002, 82, 51-61.
95. Macleod, G.S.; Fell, J.T.; Collett, J.H.; Sharma, H.L.; Smith, A.M. Selective drug delivery to the colon using pectin: chitosan:hydroxypropyl methylcellulose film coated tablets. Int. J. Pharm., 1999, 187, 251-257.
96. Bernkop-Schnurch, A.; Reich-Rohrwig, E.; Marschutz, M.; Schuhbauer, H.; Kratzel, M. Development of a sustained release dosage form for α-lipoic acid. II. Evaluation in human volunteers. Drug Dev. Ind. Pharm., 2004, 30, 35-42.
97. Lorenzo-Lamosa, M.L.; Remunan-Lopez, C.; Vila-Jato, J.L.; Alonso, M.J. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Release., 1998, 52, 109-118.
98. Li, P.; Wang, Y.; Zeng, F.; Chen, L.; Peng, Z.; Kong, L.X. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr. Res., 2011, 346, 801-806.
99. Benziger, D.P.; Edelson, J. Absorption from the vagina. Drug Metab. Rev., 1983, 14, 137-168.
100. Valenta, C. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev., 2005, 57, 1692-1712.
101. Senyigit, Z.A.; Karavana, S.Y.; Erac, B.; Gursel, O.; Limoncu, M.H.; Baloglu, E. Evaluation of chitosan based vaginal bioadhesive gel formulations for antifungal drugs. Acta Pharm., 2014, 64, 139-156.
102. Frank, L.A.; Sandri, G.; D’Autilia, F.; Contri, R.V.; Bonferoni, M.C.; Caramella, C.; Frank, A.G.; Pohlmann, A.R.; Guterres, S.S. Chitosan gel containing polymeric nanocapsules: a new fo rmulation for vaginal drug delivery. Int. J. Nanomed., 2014, 9, 3151-3161.
103. Kast, C.E.; Valenta, C.; Leopold, M.; Bernkop-Schnurch, A. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J. Control. Release, 2002, 81, 347-354.
104. Friedl, H.E.; Dunnhaupt, S.; Waldner, C.; Bernkop-Schnurch, A. Preactivated thiomers for vaginal drug delivery vehicles. Biomaterials, 2013, 34, 7811-7818.
105. Abruzzo, A.; Bigucci, F.; Cerchiara, T.; Saladini, B.; Gallucci, M.C.; Cruciani, F.; Vitali, B.; Luppi, B. Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate. Carbohydr. Polym., 2013, 91, 651-658.
106. Byrne, J.D.; Betancourt, T.; Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev., 2008, 60, 1615-1626.
107. Kim, T.H.; Jiang, H.L.; Nah, J.W.; Cho, M.H.; Akaike, T.; Cho, C.S. Receptor-mediated gene delivery using chemically modified chitosan. Biomed. Mater., 2007, 2, 95-100.
108. You, J.; Li, X.; Cui, F.; Du, Y.Z.; Yuan, H.; Hu, F.Q. Folateconjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology., 2008, 19, 045102.
109. Li, H.; Qian, Z.M. Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev., 2002, 22, 225-250.
110. Dufes, C.; Muller, J.M.; Couet, W.; Olivier, J.C.; Uchegbu, I.F.; Schatzlein, AG. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm. Res., 2004, 21, 101-107.
111. Cullinane, C.; Solomon, B.; Hicks, R. J. Imaging of molecular target modulation in oncology: challenges of early clinical trials. Clin. Transl. Imaging, 2014, 2, 5-12.
112. Li, J.; Ma, F.K.; Dang, Q.F.; Liang, X.G.; Chen, X.G. Glucoseconjugated chitosan nanoparticles for targeted drug delivery and their specific interaction with tumor cells. Front. Mater. Sci., 2014, 8, 363-372.
113. Baldrick, P. The safety of chitosan as a pharmaceutical excipient. Regul. Toxicol. Pharmacol., 2010, 56, 290-299.
114. Ren, D.; Yi, H.; Wang, W.; Ma, X. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohydr. Res., 2005, 340, 2403-2410.
115. Minami, S.; Oh-oka, M.; Okamoto, Y.; Miyatake, K.; Matsuhashi, A.; Shigemasa, Y.; Fukumoto, Y. Chitosan-inducing hemorrhagic pneumonia in dogs. Carbohydr. Polym., 1996, 29, 241-246.
116. Hathcock, J.N.; Shao, A. Risk assessment for glucosamine and chondroitin sulfate. Regul. Toxicol. Pharmacol., 2007, 47, 78-83.
117. Kulish, E. I.; Volodina, V. P.; Fatkullina, R. R.; Kolesov, S. V.; Zaiko, G. E. Macromolecular effects upon enzymatic degradation of chitosan in solution. Polymer Sci. Series B., 2008, 50, 172-174.
118. Sagnella, S.; Mai-Ngam, K. Chitosan based surfactant polymers designed to improve compatibility on biomaterials. Colloid Surf., 2005, 42, 147-155.
119. Klokkevold, P.R.; Fukayama, H.; Sung, E.C.; Bertolami, C.N. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. J. Oral Maxillofac. Surg., 1999, 57, 49-52.
120. Yao, H.T.; Huang, S.Y.; Chiang, M.T. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem. Toxicol., 2008, 46, 1525-1534.
121. Hayashi, K.; Ito, M. Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol. Pharm. Bull., 2002, 25, 188-192.
122. Kean, T.; Thanou, M. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev., 2010, 62, 3-11.
123. Bernkop-Schnurch, A.; Dunnhaupt, S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm., 2012, 81, 463-469.